NCT05161195 2026-04-02Roll-over Study to Allow Continued Access to RibociclibNovartisPhase 4 Active not recruiting134 enrolled
NCT07310420 2026-03-11A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With HR+, HER2- Advanced Breast CancerTerSera Therapeutics LLCPhase 1 Not yet recruiting88 enrolled
NCT05701007 2026-01-29Real World Evidence Study on Metastatic Prostate Cancer in the Pirkanmaa Hospital District in FinlandPfizerCompleted1,083 enrolled 29 charts
NCT03671330 2025-10-31Efficacy and Safety of Ribociclib in Pre- and Postmenopausal Chinese Women With HR Positive, HER2-negative, Advanced Breast Cancer.NovartisPhase 2 Completed327 enrolled
NCT05870579 2025-08-21[177Lu]Lu-NeoB in Combination With Ribociclib and Fulvestrant in Participants With ER+, HER2- and GRPR+ Advanced Breast CancerNovartisPhase 1 Recruiting48 enrolled